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Supplementary Material 
De Novo Asymmetric Bio- and Chemocatalytic Synthesis of Saccharides – 
Stereoselective Formal O-Glycoside Bond Formation Under Palladium 
Catalysis 
Alex C. Comely, Rienk Eelkema, Adriaan J. Minnaard and Ben L. Feringa*  




General experimental remarks: Reagents were purchased from Aldrich, Acros Chimica, Strem, Merck or Fluka and were 
used as provided unless otherwise stated. All solvents were reagent grade and were dried and distilled before use 
according to standard procedures. Removal of ethanol, used as a stabilising agent, from dichloromethane was effected by 
washing with conc. H2SO4 (x2), water (x2), 5% Na2SO4 (x2), water (x2) and drying over CaCl2 before distillation from 
CaH2. Chromatography: silica gel, Merck type 9385 230-400 mesh, TLC: silica gel 60, Merck, 0.25 mm. Optical rotations 
were measured on a Perkin Elmer 241 MC at ambient temperature. Mass spectra (HRMS) were recorded on an AEI MS-
902 by Mr. A. Kiewiet. GC analyses were performed on a HP5890 Series II using a flame ionisation detector and using 
the chiral columns specifed in the table at the end of this section. HPLC analyses were peformed on a Shimadzu 10AD-
VP using the chiral columns specifed in the table at the end of this section. 1H and 13C NMR spectra were recorded on a 
Varian Gemini-200 (50.32 MHz), Varian 300 (75.48 MHz) or Varian 500 (125.80 MHz) spectrometer in CDCl3. 




To a solution of (±)-1 (5 g, 32 mmol, prepared according to a literature procedure) in 1,4-dioxane (300ml) was added n-
butanol (11.9 g, 14.6 ml, 160 mmol) and Lipase PS-HSC (2.5 g, 30% loading w/w) and the resulting mixture was stirred 
with a mechanical over-head stirrer at ambient temperature for 48 h. The suspension was filtered through celite, eluted 
with DCM and concentrated to a pale yellow oil in vacuo. Purification by column chromatography (SiO2, hexane:EtOAc 
7:3) gave the title compound (2.07 g, 13.2 mmol, 41%) as a colourless oil which crystallised at 4 oC. The pale yellow oily 
crystals were washed with ice-cold EtOAc/pentane (1:19) to afford the highly pure title compound (1.87 g, 75%, >99% 
ee) as colourless crystals. [α]D –198º (c 1.0, CHCl3) 
 
(R)-(-)-6-Benzoyloxy-2H-pyran-3(6H)-one, (-)-3 and (S)-(+)-6-Benzoyloxy-2H-pyran-3(6H)-one, (+)-3 
 
The racemate (prepared according to a literature procedure) was resolved by preparative HPLC (Chiralpac AS column, 






























































 (R,S)-(±)-6-Benzyloxy-2H-pyran-3(6H)-one (±)-2A (prepared from (±)-6-Acetoxy-2H-pyran-3(6H)-one (±)-1) 
 
To palladium (II) acetate (11.3 mg, 5 mol%, 0.05 mmol) in a flame-dryed Schlenk tube under argon was added a solution 
of triphenylphosphite (34 mg, 11 mol%, 0.11 mmol) in DCM (2 ml) via cannula. After stirring the yellow solution at 
ambient temperature for 10 min, benzyl alcohol (162 mg, 155 µl, 1.5 mmol) was added via microsyringe. After stirring 
the resulting deep brown solution for a further 10 min a solution of (±)-6-acetoxy-2H-pyran-3(6H)-one (±)-1 (156 mg, 1 
mmol) in DCM (1 ml) was added and the mixture was stirred in the dark for 24 h. The homogeneous orange solution was 
preadsorbed on silica and purified by column chromatography (SiO2, acetone:pentane) to give the title compound  (153 
mg, 75%) as a colourless oil. Anal. Calcd. for C13H14O4: C, 70.58; H, 5.92%. Found: C, 70.55; H, 6.00. 1Η NMR (300 
MHz, CDCl3) 7.34-7.38 (m, 5 H), 6.88 (dd, 1 H, J = 10.26 and 3.3 Hz), 6.14 (d, 1 H, J = 10.26 Hz), 5.29 (d, 1 H, J = 3.66 
Hz), 4.85 (d, 1 H, J = 11.72 Hz), 4.66 (d, 1 H, J = 11.72 Hz), 4.49 (d, 1 H, J = 16.84 Hz) and 4.12 (d, 1 H, J = 16.84 Hz). 
13C NMR (75 MHz, CDCl3)  194.4, 144.2, 136.8, 128.5, 128.1, 128.1, 127.8, 92.0, 70.6 and 66.2. MS (EI): m/z 204 (M+, 
1%) and 91 (C7H7, 100). HRMS calcd. for C13H14O4: 204.07863. Found: 204.07789.  
 
(S)-(-)-6-Benzyloxy-2H-pyran-3(6H)-one, (-)-2A  
 
To palladium (II) acetate (22.5 mg, 10 mol%, 0.1 mmol) in a flame-dryed Schlenk tube under argon was added a solution 
of triphenylphosphite (68 mg, 22 mol%, 0.22 mmol) in DCM (2 ml) via cannula. After stirring the yellow solution at 
ambient temperature for 10 min, benzyl alcohol (162 mg, 155 µl, 1.5 mmol) was added via microsyringe. After stirring 
for a further 10 min the resulting mixture was cooled to –30 oC and a solution of (-)-6-acetoxy-2H-pyran-3(6H)-one (-)-1 
(156 mg, 1 mmol) in DCM (1 ml), also cooled to –30 oC, was added. The mixture was stirred in the dark for 24 h at –30 
oC. The homogeneous orange solution was preadsorbed on silica and purified by column chromatography (SiO2, 
acetone:pentane) to give the title compound  (169 mg, 83%) as a colourless oil. [α]D = -45.5o (94% ee, c 1.09, CH2Cl2) 
 
(R,S)-(±)-6-Benzyloxy-2H-pyran-3(6H)-one, (±)-2A (prepared from (±)-6-benzoyloxy-2H-pyran-3(6H)-one (±)-3)  
 
To palladium (II) acetate (5.2 mg, 5 mol%, 0.023 mmol) in a flame-dryed Schlenk tube under argon was added a solution 
of triphenylphosphite (15.6 mg, 11 mol%, 0.051 mmol) in DCM (2 ml) via cannula. After stirring the yellow solution at 
ambient temperature for 10 min, benzyl alcohol (74 mg, 71 µl, 0.69 mmol) was added via microsyringe. After stirring the 
resulting deep brown solution for a further 10 min a solution of (±)-6-benzoyloxy-2H-pyran-3(6H)-one (±)-3 (100 mg, 
0.46 mmol) in DCM (1 ml) was added and the mixture was stirred in the dark for 24 h. The homogeneous orange solution 
was preadsorbed on silica and purified by column chromatography (SiO2, acetone:pentane 5:95) to give the title 
compound  (82 mg, 87%) as a colourless oil. 
 
(R,S)-(±)-6-(4-Methoxybenzyl)oxy-2H-pyran-3(6H)-one, (±)-2B  
 
Prepared according to the procedure for (±)-2A from palladium(II) acetate (15 mg, 5 mol%, 0.07 mmol), 
triphenylphosphite (45 mg, 11 mol%, 0.15 mmol), 4-methoxybenzyl alcohol (184 mg, 1.3 mmol) and (±)-6-acetoxy-2H-
pyran-3(6H)-one 1 (250 mg, 1.6 mmol) in DCM (6 ml). Purification of the residue by column chromatography (SiO2, 
EtOAc:hexane 5:95 to 15:85 gradient elution) and distillation of remaining (±)-1 from the mixture (120 oC, 1 mmHg) 
gave product (±)-2B ( mg, 1.27 mmol, 79%) as a colourless oil. Anal. Calcd. for C13H14O4: C, 66.66; H, 6.02%. Found: C, 
66.66; H 6.07. 1Η NMR (300 MHz, CDCl3) 7.22 (d, 2 H, J = 8.79 Hz), 6.82 (d, 2 H, J = 8.42 Hz), 6.79 (dd, 1 H, J = 3.29 
and 6.96 Hz), 6.05 (d, 1 H, J = 10.62 Hz), 5.19 (d, 1 H, J = 3.29 Hz), 4.71 (d, 1 H, J = 11.35 Hz), 4.52 (d, 1 H, J = 11.35 
Hz), 4.40 (d, 1 H, J = 16.85 Hz), 4.04 (d, 1 H, J = 16.84 Hz) and 3.73 (s, 3 H). 13C NMR (75 MHz, CDCl3)  194.6, 159.5, 
144.4, 129.8, 128.8, 127.8, 113.9, 91.7, 70.3, 66.2 and 55.2. MS (EI): m/z 234 (M+, 23%) and 121 (CH3OC6H4CH2, 100). 
HRMS calcd. for C13H14O4: 234.08919. Found: 234.08864. 
 
(S)-(-)-6-(4-Methoxybenzyl)oxy-2H-pyran-3(6H)-one, (-)-2B  
 
Prepared according to the procedure for (-)-2A from palladium(II) acetate (7.2 mg, 10 mol%, 0.032 mmol), 
triphenylphosphite (22 mg, 22 mol%, 0.071 mmol), 4-methoxybenzyl alcohol (44 mg, 0.32 mmol) and (-)-6-acetoxy-2H-
pyran-3(6H)-one 1 (100 mg, 0.64 mmol) in DCM (3 ml). Purification of the residue (98% ee, HPLC) as descibed for (±)-
2B
 gave (-)-2B (65 mg, 87%, 74% ee) as a colourless oil. 
 
(R,S)-(±)-6-(3-Methoxybenzyl)oxy-2H-pyran-3(6H)-one, (±)-2C  
 
Prepared according to the procedure for (±)-2A from palladium (II) acetate (60 mg, 5 mol%, 0.27 mmol), 
triphenylphosphite (182 mg, 11 mol%, 0.59 mmol), 3-methoxybenzyl alcohol (736 mg, 5.3 mmol) and (±)-6-acetoxy-2H-
pyran-3(6H)-one (±)-1 (1.25 g, 8 mmol) in DCM (24 ml). Purification of the residue by column chromatography (SiO2, 
acetone:pentane 1:9) gave product (±)-2C (1.122 g, 90%) as a colourless oil. Anal. Calcd. for C13H14O4: C, 66.66; H, 
6.02%. Found: C, 66.52; H, 6.01. 1Η NMR (300 MHz, CDCl3) 7.23-7.29 (m, 1 H), 6.82-6.93 (m, 3 H), 6.12 (d, 1 H, J = 
10.6 Hz), 5.6 (d, 1 H, J = 3.29 Hz), 4.80 (d, 1 H, J = 11.7 Hz), 4.61 (d, 1 H, J = 11.7 Hz), 4.47 (d, 1 H, J = 16.8 Hz), 4.09 
(d, 1 H, J = 16.8 Hz) and 3.78 (s, 3 H). 13C NMR (75 MHz, CDCl3)  194.5, 159.7, 144.2, 138.3, 129.5, 129.4, 127.8, 
120.2, 113.48, 113.45, 91.9, 70.4, 66.2 and 55.1. MS (EI): m/z 234 (M+, 8%) and 122 (CH3OC6H4CH3, 100). HRMS 
calcd. for C13H14O4: 234.08919. Found: 234.09062.  
 
(S)-(-)-6-(3-Methoxybenzyl)oxy-2H-pyran-3(6H)-one, (-)-2C  
Prepared according to the procedure for (-)-2A from palladium (II) acetate (45 mg, 10 mol%, 0.2 mmol), 
triphenylphosphite (136 mg, 22 mol%, 0.44 mmol), 3-methoxybenzyl alcohol (276 mg, 2 mmol) and (-)-6-acetoxy-2H-
pyran-3(6H)-one (-)-1 (468 mg, 3 mmol) in DCM (6 ml). Purification of the residue as descibed for (±)-2C gave (-)-2C 






To a solution of iodopropane (10.2 g, 5.9 ml, 0.6 mmol) in DMF (100 ml) at ambient temperature was added Cs2CO3 (9.8 
g, 0.3 mmol) and 5-hydroxy-2-nitrobenzaldehyde (5 g, 0.3 mmol) and the resulting mixture was stirred for 36 h. After 
diluting with water (50 ml) and extraction with EtOAc (3 x 50 ml) the organic layers were dried with MgSO4 and 
concentrated to an orange oil. Trituration with hexane (50 ml) gave a pale brown precipitate which was filtered and dried 
in vacuo to give 2-nitro-5-n-propoxybenzaldehyde (4.92 g, 79%) as a pale brown solid which was not purified further. 
Anal. Calcd. for C10H11NO4: C, 57.41; H, 5.30; N, 6.70%. Found: C, 57.36; H, 5.35; N, 6.69. 1Η NMR (300 Mz, CDCl3) 
10.47 (s, 1 H), 8.14 (d, 1 H, J = 9.15 Hz), 7.30 (d, 1 H, J = 2.93 Hz), 7.13 (dd, 1 H, J = 8.79 and 2.56 Hz), 4.06 (t, 2 H, J = 
6.23 Hz), 1.86 (m, 2 H), 1.05 (t, 3 H, J = 7.32 Hz). 13C NMR (75 Mz, CDCl3) 188.61, 163.64, 141.97, 127.22, 118.84, 
113.68, 70.78, 22.21, 10.30. MS (EI): m/z 209 (M+, 5%), 167 (M – C3H6, 100). HRMS calcd. for C10H11NO4: 209.06878. 
Found: 209.06983. 
 












i. nPrI, Cs2CO3, DMF; ii. NaBH4, THF
To a solution of  2-nitro-5-n-propoxybenzaldehyde (4.5 g, 21.5 mmol) in THF (45 ml) at 0 oC was added NaBH4 (818 mg, 
21.5 mmol) and ethanol (1 ml). After stirring for 30 min at 0 oC and 30 min at ambient temperature the mixture was 
cooled again to 0 oC, quenched with satd. NH4Cl (50 ml) and extracted with EtOAc (3 x 50 ml). The organic layers were 
washed with brine and dried over MgSO4 to give a pale yellow solid (4.5 g, quant) which was not purified further. Anal. 
Calcd. for C10H11NO4: C, 56.87; H, 6.20; N, 6.63%. Found: C, 56.68; H, 6.24; N, 6.56. 1Η NMR (200 MHz, CDCl3) 8.14 
(d, 1 H, J = 9.28 Hz), 7.19 (d, 1 H, J = 2.68 Hz), 6.85 (dd, 1 H, J = 9.28 and 2.93 Hz), 4.96 (s, 2 H), 4.02 (t, 2 H, J = 6.35 
Hz), 2.77 (brs, 1 H), 1.83 (sextet, 2 H, J = 7.57 Hz), 1.04 (t, 3H, J = 7.32 Hz). 13C NMR (50 MHz, CDCl3) 163.83, 140.2, 
139.90, 127.93, 114.47, 113.41, 70.26, 62.87, 22.27, 10.33. MS (EI): m/z 211 (M+, 62%), 194 (M – OH, 17) and 43 (C3H7, 
100). HRMS calcd. for C10H13NO4: 211.08443. Found: 211.08535.  
 
(R,S)-(±)-6-(2-Nitro-5-n-propoxybenzyl)oxy-2H-pyran-3(6H)-one, (±)-2D  
 
Prepared according to the procedure for (±)-2A from palladium (II) acetate (11 mg, 5 mol%, 0.047 mmol), 
triphenylphosphite (32 mg, 11 mol%, 0.104 mmol), 2-nitro-5-n-propoxybenzyl alcohol (200 mg, 0.95 mmol) and (±)-6-
acetoxy-2H-pyran-3(6H)-one (±)-1 (222 mg, 1.42 mmol) in DCM (4 ml). Purification of the residue by column 
chromatography (SiO2, acetone:pentane 1:9 to 1:4 gradient elution) gave product (±)-2D (230 mg, 79%) as a colourless 
waxy solid. Anal. Calcd. for C15H17NO6: C, 58.63; H, 5.58; N, 4.56%. Found: C, 58.75; H, 5.51; N, 4.61. 1Η NMR (300 
MHz, CDCl3) 8.19 (d, 1 H, J = 9.16 Hz), 7.21 (d, 1 H, J = 2.56 Hz), 6.99 (dd, 1 H, J = 3.30 and 10.25 Hz), 6.88 (dd, 1 H, 
J = 2.93 and 9.16 Hz), 6.21 (d, 1 H, J = 10.62 Hz), 5.41 (d, 1 H, J = 3.29 Hz), 5.27 (d, 1 H, J = 15.01 Hz), 5.10 (d, 1 H, J 
= 15.02 Hz), 4.48 (d, 1 H, J = 16.84 Hz), 4.16 (d, 1 H, J = 16.84 Hz), 4.01 (t, 2 H, J = 6.6 Hz), 1.85 (sextet, 2 H, J = 7.32 
Hz) and 1.06 (t, 3 H, J = 7.32 Hz). 13C NMR (75 MHz, CDCl3) 194.2, 163.5, 143.7, 139.6, 136.8, 128.0, 127.7, 114.0, 
112.6, 93.1, 70.1, 67.9, 66.3, 22.2 and 10.3. MS (EI): m/z 307 (M+, 3%), 210 (M – C5H5O2, 27), 194 (M - C5H5O3, 100) 
and 178 (M - C5H5O4, 34). HRMS calcd. for C15H17NO6: 307.10555. Found: 307.10469.  
 
 
(S)-(-)-6-(2-Nitro-5-n-propoxybenzyl)oxy-2H-pyran-3(6H)-one, (-)-2D  
 
Prepared according to the procedure for (-)-2A from palladium (II) acetate (34 mg, 10 mol%, 0.15 mmol), 
triphenylphosphite (102 mg, 22 mol%, 0.33 mmol), 2-nitro-5-n-propoxybenzyl alcohol (317 mg, 1.5 mmol) and (-)-6-
acetoxy-2H-pyran-3(6H)-one (-)-1 (468 mg, 3 mmol) in DCM (9 ml). Purification of the residue as descibed for (±)-2D 
gave (-)-2D (388 mg, 84%, >98% ee) as a colourless waxy solid. [α]D =  -94.9º (98% ee, c 0.78, CH2Cl2) 
 Phenolic polystyrene-supported 2-Nitro-5-n-propoxybenzyl alcohol, E  
Spectra included: 13C NMR 
 
To a suspension of phenolic polystyrene (500 mg, 1.45 mmol[O]g-1, 0.725 mmol, 1% DVB) in DMF (10 ml) was added 
Cs2CO3 (473 mg, 1.45 mmol) and 5-(3-iodopropoxy)-2-nitrobenzyl alcohol (489 mg, 1.45 mmol). After shaking at 
ambient temperature for 60 h the resin was filtered and washed with THF/H2O (1:1 at 0 oC rapidly, 0:1 at RT, 1:1, 3:1 and 
9:1; 2 x 20ml each), THF (2 x 2 ml) and CH2Cl2 (2 x 2ml). The resulting yellow residue was dried in vacuo for 24 h to 
give resin E (582 mg, 54%, 0.67 mmol[linker]g-1). 13C−NMR (75 MHz, CDCl3–swollen resin) diagnostic signals 163.0 
(Car-O), 113.3 and 112.8 (2 x Car-H), 65.3 (2 x Car-O-CH2), 62.7 (Car-CH2) and 29.0 (CH2-CH2-CH2). νmax cm-1  1511 
(asymm/symm N=O), 1322 (C-NO2). 
 
Phenolic polystyrene-supported-(R,S)-6-(2-Nitro-5-n-propoxybenzyl)oxy-2H-pyran-3(6H)-one, 2E 
Spectra included: 13C NMR 
 
To a suspension of resin E (200 mg, 0.134 mmol) in CH2Cl2 (1 ml) under Ar was added a solution of Pd(OAc)2 (3 mg, 
0.0134 mmol) and triphenylphosphite (9 mg, 0.0295 mmol) in CH2Cl2 (0.5 ml) via cannula. The resulting mixture was 
shaken for 10 min before addition of a solution of 6-acetoxy-2H-pyran-3(6H)-one (±)-1 (42 mg, 0.268 mmol) in CH2Cl2 
(0.5 ml) via cannula. After shaking for 24 h, the resin was filtered and washed with CH2Cl2 (2 x 2 ml), THF/H2O (1:1, 3:1 
and 9:1; 2 x 2ml each), THF (2 x 2 ml) and CH2Cl2 (2 x 2ml). The resulting black residue was dried in vacuo to give 2E 
(209 mg, 69%). 13C−NMR (50.3 MHz, CDCl3–swollen resin) diagnostic signals 194.1 (C=O), 163.3 (Car-O), 143.6 
(CH=CH-C=O), 113.3 and 112.6 (2 x Car-H), 93.2 (CH-O), 68.0 and 65.3 (2 x Car-O-CH2) , 66.5 (CH2-C=O), 62.6 (Car-
CH2)and 28.9 (CH2-CH2-CH2). νmax cm-1 1703 (s, C=O), 1512 (asymm/symm N=O), 1323 (C-NO2). 
 
6(R,S)-(Fmoc-Ser-OMe)-2H-pyran-3(6H)-one, 6(R,S)-2F  
 
Prepared according to the procedure for (±)-2A from palladium (II) acetate (3.3 mg, 5 mol%, 0.015 mmol), 
triphenylphosphite (10 mg, 11 mol%, 0.032 mmol), Fmoc-Ser-OMe (100 mg, 0.29 mmol) and (±)-6-acetoxy-2H-pyran-
3(6H)-one (±)-1 (69 mg, 0.44 mmol) in DCM (3 ml). Purification of the residue by column chromatography (SiO2, 
EtOAc/pentane 1:4 to 3:7 gradient elution) gave product 6(R,S)-2F (35 mg, 27%) as a mixture of 2 diastereomers (1:1) as 
a colourless solid foam. Anal. Calcd. for C24H23NO7: C, 65.90; H, 5.30; N, 3.20%. Found: C, 65.6; H, 5.5; N, 2.9. 
1Η NMR (300 MHz, CDCl3) 7.77 (d, 2 H, J = 7.32 Hz), 7.62-7.60 (m, 2 H), 7.44-7.30 (m, 4 H), 6.87-6.79 (m, 1 H), 6.14 
(d, 1 H, J = 10.26 Hz), 5.75-5.62 (m, 1 H), 5.18 (brs, 1 H), 4.62-4.58 (m, 1 H), 4.51-4.06 (m, 6 H) and 3.89-3.71 (m, 4 H). 
13C NMR (75 MHz, CDCl3) 194.1, 193.9, 170.3, 170.1, 155.8, 143.7, 143.6, 143.4, 141.2, 128.0, 128.0, 127.7, 127.0, 
125.0, 119.9, 93.6, 93.1, 69.4, 68.7, 67.1, 67.0, 66.4, 66.1, 54.2, 54.0, 52.7, 47.0 and 47.0. MS (EI): m/z 437 (M+, 1%), 
378 (M – CO2CH3, 1) and 178 (C14H10, 100). HRMS calcd. for C15H17NO6: 437.14745. Found: 437.14655.  
 
6(S)-(Fmoc-Ser-OMe)-2H-pyran-3(6H)-one, 6(S)-2F  
 
Prepared according to the procedure for (-)-2A from palladium (II) acetate (4.5 mg, 10 mol%, 0.02 mmol), 
triphenylphosphite (14 mg, 22 mol%, 0.044 mmol), Fmoc-Ser-OMe (68 mg, 0.2 mmol) and (-)-6-acetoxy-2H-pyran-
3(6H)-one (-)-1 (47 mg, 0.3 mmol) in DCM (1.5 ml). Purification of the residue as descibed for 6(R,S)-2F gave 6(S)-2F 
(68 mg, 78%, 97% ee) as a colourless solid foam. 1Η NMR (300 MHz, CDCl3) 7.77 (d, 2 H, J = 7.7 Hz), 7.59-7.58 (m, 2 
H), 7.43-7.29 (m, 4 H), 6.81 (dd, 1 H, J = 10.3 and 2.9 Hz), 6.14 (d, 1 H, J = 10.25 Hz), 5.77 (d, 1 H, J = 8.42 Hz), 5.18 
(brs, 1 H), 4.61-4.58 (m, 1 H), 4.45-4.37 (m, 3 H), 4.24 (t, 1 H, J = 7.0 Hz), 4.13-4.07 (m, 3 H) and 3.78 (s, 3 H). 
13C NMR (75 MHz, CDCl3) 193.9, 170.3, 155.9, 143.7, 143.6, 143.3, 141.3, 128.1, 127.7, 127.0, 125.0, 124.9, 120.0, 
93.7, 69.5, 67.2, 66.4, 54.2, 52.7 and 47.0. [α]D = -22.2º  (97% ee, c 1.80, CH2Cl2). 
 
6(R,S)-O-(6-oxo-2H-pyran-3(6H)-one)-1,2,3,4-tetra-O-acetyl-β-D-glucopyranoside, 6(R,S)-2G  
 
Prepared according to the procedure for (±)-2A from palladium (II) acetate (11.3 mg, 10 mol%, 0.05 mmol), 
triphenylphosphite (34 mg, 22 mol%, 0.11 mmol), 1,2,3,4-tetra-O-acetyl-β-D-glucopyranose (174 mg, 0.5 mmol) and (±)-
6-acetoxy-2H-pyran-3(6H)-one (±)-1 (156 mg, 1.0 mmol) in DCM (2 ml). Purification of the residue by column 
chromatography (SiO2, EtOAc/pentane 2:3) gave 2 diastereomers (ratio 0.45:0.55) of product 6(R,S)-2G (191 mg, 86%) 
as a colourless foam. 1H NMR (300 MHz, CDCl3): δ 6.89 (dd, J = 8.79, 3.30 Hz, 0.55 H, diastereomer), 6.86 (dd, J = 
10.25, 3.66 Hz, 0.45H, diastereomer), 6.12 (d, J = 10.25 Hz, 1 H), 5.69 (d, J = 7.33, 0.45 H), 5.67 (d, J = 6.95, 0.55 H), 
5.29-5.07 (m, 4 H), 4.45 (d, J = 16.11 Hz, 0.55 H), 4.39 (d, J = 16.84 Hz, 0.45 H), 4.06 (d, J = 17.95 Hz, 0.55 H), 4.02 (d, 
J = 16.48 Hz, 0.45 H), 3.88-3.61 (m, 3H), and 2.05 (m, 12 H). 13C NMR (75 MHz, CDCl3): 194.3, 194.2, 170.0, 169.9, 
169.4, 169.2, 169.1, 169.1, 168.9, 168.8, 143.7, 143.4, 127.8, 127.1, 93.9, 93.0, 91.6, 91.6, 74.0, 73.3, 72.8, 72.7, 70.1, 
70.0, 68.3, 68.2, 67.1, 66.4, 66.10. 66.05, 20.6, 20.5 and 20.4. 
 
 
6(S)-O-(6-oxo-2H-pyran-3(6H)-one)-1,2,3,4-tetra-O-acetyl-β-D-glucopyranoside, 6(S)-2G  
Spectra included: 1H and 13C NMR 
 
(From (-)-6-Acetoxy-2H-pyran-3(6H)-one (-)-1) 
Prepared according to the procedure for (-)-2A from palladium (II) acetate (5.6 mg, 10 mol%, 0.025 mmol), 
triphenylphosphite (17.1 mg, 22 mol%, 0.055 mmol), 1,2,3,4-tetra-O-acetyl-β-D-glucopyranose (87 mg, 0.25 mmol) and 
(-)-6-acetoxy-2H-pyran-3(6H)-one (-)-1 (59 mg, 0.375 mmol) in DCM (1 ml) at –5 oC. Purification of the residue (94% 
de, 1H NMR) by flash chromatography (SiO2, 20-50% EtOAc/pentane gradient elution) gave the product 6(S)-2G (86 mg, 
77%) as a colourless foam. [α]D = -14.8º  (c 1.76, CH2Cl2). 1H NMR (300 MHz, CDCl3): 6.87 (dd, J = 10.25 and 3.29 Hz, 
1H), 6.13 (d, J = 10.26 Hz, 1 H), 5.70 (d, J = 8.06 Hz, 1 H), 5.28-5.09 (m, 4 H), 4.40 (d, J = 16.84 Hz, 1 H), 4.03 (d, J = 
16.85 Hz, 1 H), 3.90-3.75 (m, 3 H), 2.10 (s, 3 H), 2.03 (s, 6 H) and 2.01 (s, 3 H). 13C NMR (75 MHz, CDCl3): 194.2, 
170.1, 169.3, 169.2, 168.9, 143.4, 127.9, 93.1, 91.7, 73.4, 72.9, 70.1, 68.4, 66.5, 66.2, 20.7, 20.6, 20.5 and 20.5. MS (CI) 
for C19H24O12: m/z 462 (M+NH4+, 100%). HRMS (M-CH2O) calcd. for C18H22O11: 414.11615. Found: 414.11651. 
 
(From (-)-6-Benzoyloxy-2H-pyran-3(6H)-one, (-)-3 ) 
To Pd2(dba)3 (1.4 mg, 5 mol%, 1.5 µmol) and ), triphenylphosphine (1.8 mg, 22 mol%, 6.7 µmol) and molecular sieves (4 
Å) in a flame-dried Schlenk tube under argon was added DCM (1 ml). After stirring the resulting yellow solution at 
ambient temperature for 10 min, 1,2,3,4-tetra-O-acetyl-β-D-glucopyranose (11 mg, 0.031 mmol) was added as a solid. 
After a further 10 min stirring and cooling of the mixture to –10 oC, (-)-6-benzoyloxy-2H-pyran-3(6H)-one (-)-3 (10 mg, 
0.046 mmol) was added as a solid and the mixture was stirred in the dark. After 16 h, purification of the residue (94% de, 
1H NMR) by flash chromatography (SiO2, EtOAc/hexane 3:7 to 3.5:6.5 gradient elution) gave product 6(S)-2G (12 mg, 














Spectra included: 1H and 13C NMR 
 
(From (+)-6-Benzoyloxy-2H-pyran-3(6H)-one, (+)-3 ) 
Prepared according to the procedure for 6(S)-2G from Pd2(dba)3 (1.4 mg, 5 mol%, 1.5 µmol), triphenylphosphine (1.8 mg, 
22 mol%, 6.7 µmol), 1,2,3,4-tetra-O-acetyl-β-D-glucopyranose (11 mg, 0.031 mmol) and (+)-6-benzoyloxy-2H-pyran-
3(6H)-one (+)-3 (10 mg, 0.046 mmol) in DCM (1 ml) under Ar at –10 oC. After 16 h, purification of the residue (98% de 
by 1H NMR) by flash column chromatography (SiO2, EtOAc/hexane 3:7 to 3.5:6.5 gradient elution) gave product 6(R)-
2G
 (13 mg, 96%) as a colourless oil. [α]D = +36.7o  (c 0.6, CH2Cl2). 1H NMR (300 MHz, CDCl3): 6.90 (dd, J = 10.62 and 
3.67 Hz, 1H), 6.13 (d, J = 10.25 Hz, 1 H), 5.68 (d, J = 8.42 Hz, 1 H), 5.26 (dd, J = 9.52 and 9.52 Hz, 1 H), 5.15-5.08 (m, 3 
H), 4.46 (d, J = 16.85 Hz, 1 H), 4.07 (d, J = 16.84 Hz, 1 H), 3.91 (dd, J = 11.71 and 2.20 Hz, 1 H), 3.86-3.80 (m, 1 H), 
3.64 (dd, J = 11.72 and 5.12 Hz, 1 H), 2.10 (s, 3 H), 2.04 (s, 3 H), 2.03 (s, 3 H) and 2.01 (s, 3 H). 13C NMR (75 MHz, 
CDCl3): 194.4, 170.1, 169.5, 169.2, 169.0, 143.7, 127.9, 94.0, 91.7, 74.1, 72.9, 70.2, 68.3, 67.2, 66.2, 20.8, 20.6, 20.5 and 




Prepared according to the procedure for 6(S)-2G from Pd2(dba)3 (29 mg, 5 mol%, 0.025 mmol), triphenylphosphite (34 
mg, 22 mol%, 0.11 mmol), 1,2,3,6-tetra-O-acetyl-β-D-glucopyranose (174 mg, 0.5 mmol) and (±)-6-acetoxy-2H-pyran-
3(6H)-one (±)-1 (156 mg, 1.0 mmol) in DCM (6 ml) with under Ar at ambient temperature. After 16 h, purification of the 
residue by column chromatography (SiO2, EtOAc/hexane 3:7 to 1:1 gradient elution) gave product 6(R,S)-2H (130 mg, 
59%) as a mixture of diastereomers (6:4) as a colourless glassy solid. 1H NMR (300 MHz, CDCl3): δ 6.81 (dd, J = 10.25 
and 3.29 Hz, 0.6 H diastereomer), 6.62 (dd, J = 10.62 and 3.30 Hz, 0.4 H diastereomer), 6.10 (d, J = 10.25 Hz, 0.4 H 
diastereomer), 6.08 (d, J = 10.25 Hz, 0.6 H diastereomer), 5.69 (d, J = 8.42 Hz, 1 H), 5.33 (d, J = 3.29 Hz, 0.4 H 
diastereomer), 5.34-5.00 (m, 2 H), 5.11 (d, J = 3.30 Hz, 0.6 H diasteroemer), 4.44-4.22 (m, 3H), 4.06-3.72 (m, 3H) and 








142.8, 142.7, 128.0, 127.4, 95.0, 94.6, 91.3, 91.3, 76.9, 74.9, 74.4, 73.4, 73.4, 73.1, 70.5, 70.4, 66.7, 66.5, 62.1, 61.5, 
20.64, 20.64, 20.61, 20.61, 20.58, 20.5, 20.4 and 20.4. MS (CI) for C19H24O12: m/z 462 (M + NH4)+. 
 
4-O-(6(R)-oxo-2H-pyran-3(6H)-one)-1,2,3,6-tetra-O-acetyl-β-D-glucopyranoside, 6(R)-2H 
Spectra included: 1H and 13C NMR 
 
 (From (-)-6-Acetoxy-2H-pyran-3(6H)-one (-)-1) 
Prepared according to the procedure for 6(S)-(-)-2G from Pd2(dba)3 (4.6 mg, 5 mol%, 0.005 mmol), triphenylphosphine 
(5.8 mg, 22 mol%, 0.022 mmol), 1,2,3,6-tetra-O-acetyl-β-D-glucopyranose (35 mg, 0.1 mmol) and (-)-6-acetoxy-2H-
pyran-3(6H)-one (-)-1 (23 mg, 0.15 mmol) in DCM (2 ml) under Ar at –10 oC. After 16 h, purification of the residue 
(91% de, 1H NMR) by flash column chromatography (SiO2, EtOAc/hexane 3:7 to 1:1 gradient elution) gave product 6(R)-
2H
 (29 mg, 65%) as a colourless oil. Anal. Calcd. for C19H24O12: requires: C, 51.35; H, 5.44%. Found: C, 51.5; H, 5.6. 
[α]D = -32.6  (c 0.95, CH2Cl2). 1H NMR (300 MHz, CDCl3): δ 6.62 (dd, J = 10.26 and 3.3 Hz, 1H), 6.12 (d, J = 10.62 Hz, 
1H), 5.70 (d, J = 8.42 Hz, 1H), 5.34 (d, J = 2.93 Hz, 1 H), 5.28 (dd, J = 9.16 and 9.16 Hz, 1 H), 5.05 (dd, J = 9.52 and 
8.05 Hz, 1 H), 4.37-4.25 (m, 3 H), 4.08-3.98 (m, 2 H), 3.79-3.73 (m, 1 H), 2.10 (s, 6 H), 2.09 (s, 3 H) and 2.02 (s, 3 H). 
13C NMR (CDCl3, 75 MHz): 193.2, 170.5, 169.6, 169.5, 168.8, 142.7, 128.2, 94.8, 91.4, 75.1, 74.5, 73.3, 70.5, 66.8, 62.2, 
20.72, 20.70, 20.65 and 20.5. MS (CI) for C19H24O12: m/z 462 (M + NH4)+. 
 
(From (-)-6-benzoyloxy-2H-pyran-3(6H)-one (-)-3) 
Prepared according to the procedure for 6(S)-2G from Pd2(dba)3 (4.6 mg, 5 mol%, 0.005 mmol), triphenylphosphine (5.8 
mg, 22 mol%, 0.022 mmol), 1,2,3,6-tetra-O-acetyl-β-D-glucopyranose (35 mg, 0.1 mmol) and (-)-6-benzoyloxy-2H-
pyran-3(6H)-one (-)-3 (33 mg, 0.15 mmol) in DCM (2 ml) under Ar at –10 oC. After 16 h, purification of the residue 
(92% de, 1H NMR) by flash column chromatography (SiO2, EtOAc/hexane 3:7 to 1:1 gradient elution) gave product 6(R)-
2H













Spectra included: 1H and 13C NMR 
 
 
(From (+)-6-Benzoyloxy-2H-pyran-3(6H)-one, (+)-3) 
Prepared according to the procedure for 6(S)-2G from Pd2(dba)3 (4.6 mg, 5 mol%, 0.005 mmol), triphenylphosphine (5.8 
mg, 22 mol%, 0.022 mmol), 1,2,3,6-tetra-O-acetyl-β-D-glucopyranose (35 mg, 0.1 mmol) and (+)-6-Benzoyloxy-2H-
pyran-3(6H)-one (+)-3 (33 mg, 0.15 mmol) in DCM (2 ml) under Ar at –10 oC. After 16 h, purification of the residue 
(96% de, 1H NMR) by flash column chromatography (SiO2, EtOAc/hexane 3:7 to 1:1 gradient elution) gave product 6(S)-
2H
 (27 mg, 61 %) as a colourless oil. [α]D =  -18.9º (c 0.45, CH2Cl2). 1H NMR (CDCl3, 300 MHz): δ 6.82 (dd, J = 10.62 
and 3.66 Hz, 1H), 6.12 (d, J = 10.25 Hz, 1H), 5.71 (d, J = 8.42 Hz, 1H), 5.27 (dd, J = 8.79 and 8.79 Hz, 1 H), 5.15 (d, J = 
3.29 Hz, 1 H), 5.06 (dd, J = 8.42 and 8.42 Hz, 1 H), 4.45 (dd, J = 12.45 and 3.66 Hz, 1 H), 4.36 (d, J = 16.84 Hz, 1 H), 
4.26 (dd, J = 12.08 and 1.46 Hz, 1 H), 4.00 (d, J = 16.84 Hz, 1 H), 3.85 (dd, J = 9.89 and 9.89 Hz, 1 H), 3.76-3.72 (m, 1 
H), 2.14 (s, 3 H), 2.11 (s, 3 H), 2.06 (s, 3 H) and 2.03 (s, 3 H). 13C NMR (75 MHz, CDCl3): 193.7, 170.7, 170.1, 169.5, 
168.9, 142.9, 127.6, 95.2, 91.5, 76.6, 73.6, 73.6, 70.6, 66.7, 61.6, 20.8, 20.8, 20.8 and 20.6. MS (CI) for C19H24O12: m/z 





Prepared according to the procedure for (±)-2A from palladium (II) acetate (5.6 mg, 5 mol%, 0.025 mmol), 
triphenylphosphite (11.1 mg, 11 mol%, 0.055 mmol), diacetone-D-glucose (130 mg, 0.5 mmol) and (±)-6-acetoxy-2H-
























(SiO2, 10-15% EtOAc/pentane, gradient elution) gave 2 diastereomers (crude ratio 2:3) of product 2I (68 mg, 38% and 49 
mg, 27 %) both as colourless oils: 
 
Fraction 1 6(R)-[5-(2,2-Dimethyl-[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yloxy]-6H 
-pyran-3-one, 6(R)-2I 
Spectra included: 1H and 13C NMR 
 
Anal. Calcd. for C17H24O8: C, 57.30; H, 6.79%. Found: C, 57.4; H, 6.9.[α]D = -44.8  (c 3.30, CH2Cl2). 1H NMR (CDCl3, 
300 MHz) 6.85 (dd, J = 10.26 and 3.30 Hz, 1 H), 6.14 (d, J = 10.25 Hz, 1 H), 5.87 (d, J = 3.29 Hz, 1 H), 5.46 (d, J = 2.0 
Hz, 1 H), 4.60 (d, J = 3.66 Hz, 1 H), 4.44 (d, J = 16.48 Hz, 1 H), 4.34 (s, 1 H), 4.20-4.08 (m, 4 H), 3.98 (m, 1 H), 1.50 (s, 
3 H), 1.42 (s, 3 H), 1.35 (s, 3 H) and 1.32 (s, 3 H). 13C NMR (CDCl3, 75 MHz) 193.8, 143.5, 128.0, 112.2, 109.4, 105.5, 
94.7, 84.3, 82.1, 81.4, 72.7, 68.0, 66.6, 27.0, 26.9, 26.3 and 25.4. MS (CI) for C17H24O8: m/z 374 (M + NH4)+, 100%). 
 
Fraction 2 6(S)-[5-(2,2-Dimethyl-[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yloxy]-6H 
-pyran-3-one, 6(S)-2I 
Spectra included: 1H and 13C NMR 
 
[α]D = - 3.5 (c 1.65, CH2Cl2). 1H NMR (300 MHz, CDCl3) 6.83 (dd, J = 10.25 and 3.30 Hz, 1 H), 6.14 (d, J = 10.62 Hz, 1 
H), 5.88 (d, J = 3.66 Hz, 1 H), 5.35 (d, J = 3.30 Hz, 1 H), 4.74 (d, J = 17.2 Hz, 1 H), 4.54 (d, J = 3.66 Hz, 1 H), 4.47 (d, J 
= 2.93 Hz, 1 H), 4.28-4.21 (m, 1 H), 4.12-4.02 (m, 3 H), 3.94 (dd, J = 8.79 and 5.13 Hz, 1 H), 1.48 (s, 3 H), 1.39 (s, 3 H), 
1.30 (s, 3 H) and 1.27 (s, 3 H). 13C NMR (75 MHz, CDCl3) 194.6, 143.1, 128.3, 112.0, 109.2, 105.2, 90.3, 82.4, 80.8, 






(From (-)-6-Acetoxy-2H-pyran-3(6H)-one (-)-1) 
Prepared according to the procedure for 6(S)-2G from tris(dibenzylideneacetone)dipalladium (0)  (4.6 mg, 5 mol%, 0.005 
mmol), triphenylphosphine (5.8 mg, 22 mol%, 0.022 mmol), diacetone-D-glucose (26 mg, 0.1 mmol) and (-)-6-acetoxy-
2H-pyran-3(6H)-one (-)-1 (23 mg, 0.15 mmol) in DCM (2 ml) under argon at –20 oC. Purification of the residue (97% de, 
1H NMR) by column chromatography (SiO2, 10-15% EtOAc/pentane, gradient elution) gave product 6(R)-2I (25 mg, 
70%) as a colourless oil. 
 
(From
 (-)-6-Benzoyloxy-2H-pyran-3(6H)-one, (-)-3) 
Prepared according to the procedure for 6(S)-2G from tris(dibenzylideneacetone)dipalladium (0)  (2.7 mg, 5 mol%, 0.003 
mmol), triphenylphosphine (3.5 mg, 22 mol%, 0.013 mmol), diacetone-D-glucose (16 mg, 0.06 mmol) and (-)-
benzoyloxy-2H-pyran-3(6H)-one (-)-3 (20 mg, 0.09 mmol) in DCM (1.5 ml) under argon at –10 oC. Purification of the 
residue (82% de, 1H NMR) by flash column chromatography (SiO2, 10-15% EtOAc/pentane, gradient elution) gave 







 (+)-6-Benzoyloxy-2H-pyran-3(6H)-one, (+)-3) 
Prepared according to the procedure for 6(S)-2G from tris(dibenzylideneacetone)dipalladium (0)  (2.7 mg, 5 mol%, 0.003 
mmol), triphenylphosphine (3.5 mg, 22 mol%, 0.013 mmol), diacetone-D-glucose (16 mg, 0.06 mmol) and (+)-
benzoyloxy-2H-pyran-3(6H)-one (+)-3 (20 mg, 0.09 mmol) in DCM (1.5 ml) under argon at –10 oC. Purification of the 
residue (95% de, 1H NMR) by flash column chromatography (SiO2, 10-15% EtOAc/pentane, gradient elution) gave 














Spectra included: 1H and 13C NMR 
 
Prepared according to the procedure for (±)-2A from palladium (II) acetate (4.5 mg, 10 mol%, 0.02 mmol), 
triphenylphosphite (13.6 mg, 22 mol%, 0.044 mmol), 2,3,4,6-tetra-O-benzyl-D-glucopyranose (108 mg, 0.2 mmol) and 
(±)-6-acetoxy-2H-pyran-3(6H)-one (±)-1 (94 mg, 0.6 mmol) in DCM (2 ml). Purification of the residue by column 
chromatography (SiO2, 5-15% acetone/pentane, gradient elution) gave 4 diastereomers (ratio 
0.45(A):0.25(B):0.15(A):0.15(B)) of product 2J (96 mg, 76%) as a colourless oil. 1H NMR (CDCl3, 300 MHz) 7.36-7.22 
(m, 18 H), 7.19-7.17 (m, 2 H), 6.99 (dd, J = 10.62 and 3.67, 0.60 H diastereomers A), 6.84 (dd, J = 10.25 and 3.29 Hz, 
0.15 H diastereomers B), 6.75 (dd, J = 10.26 and 3.30 Hz, 0.25 H diastereomers B), 6.23 (d, J = 10.62 Hz, 0.6 H 
diastereomers A), 6.18 (d, J = 10.62 Hz, 0.4 H diastereomers B), 5.71 (d, J = 3.67 Hz, 0.45 H diastereomers A), 5.53 (d, J 
= 3.29 Hz, 0.15 H diastereomers B), 5.48 (d, J = 3.29 Hz, 0.25 H diastereomers B), 5.37 (d, J = 3.66 Hz, 0.15 H 
diastereomers A), 5.04-4.41 (m, 10 H), 4.16-3.99 (m, 1 H), 3.76-3.68 (m, 4 H) and 3.58-3.53 (m, 2 H). 13C NMR (CDCl3, 
75 MHz) 194.3, 194.1, 143.9, 143.3, 143.0, 138.3, 137.9, 137.8, 137.7, 128.4, 128.3, 128.24, 128.16, 128.04, 127.97, 
127.89, 127.86, 127.74, 127.68, 127.6, 102.2, 98.0, 94.0, 93.8, 89.0, 88.8, 84.8, 84.7, 82.4, 81.7, 81.6, 79.4, 77.5, 75.7, 
75.6, 75.3, 75.2, 75.1,75.0, 73.43, 73.37, 73.3, 71.2, 68.5, 68.4, 66.7, 66.4 and 66.2. MS (CI) for C39H40O8: m/z 654 (M + 















i. RuCl3.3H2O (20 mol%), NaIO4; ii. 2,2-DMP, Acetone, PTSA; iii. Zn(BH4)2; 

















 4-(3-Methoxy-benzyloxy)-2,2-dimethyl-dihydro-[1,3]dioxolo[4,5-c]pyran-7-one, (±)-4C 
 
To ruthenium (III) chloride trihydrate (65 mg, 0.25 mmol) under argon was added a solution of sodium metaperiodate 
(396 mg, 1.85 mmol) in water (3 ml). The resulting deep red solution was added via cannula to a solution of (±)-6-(3-
methoxybenzyl)oxy-2H-pyran-3(6H)-one, (±)-2C (289 mg, 1.24 mmol) in a mixture of MeCN (9 ml) and EtOAc (9 ml) 
at –5 oC under argon. After stirring the mixture for 25 min, a saturated aqueous solution of Na2S2O3 (15 ml) was added 
and the mixture was extracted with EtOAc (3 x 20 ml). Tho organic layers were dried over Na2SO4 and concentrated to 
give the dihydroxy compound (276 mg) as a colourless wax which was protected directly as the dioxolane. 
To a solution of the resulting dihydroxy compound in acetone (10 ml) was added 2,2-dimethoxypropane (1 ml) and para-
toluenesulfonic acid (4 mg). After stirring for 2 h at ambient temperature the mixture was quenched with saturated 
aqueous NaHCO3 (10 ml) and extracted with EtOAc (4 x 5 ml). The combined organic layers were dried over Na2SO4 
and filtered. The solution was preadsorbed onto silica and purified by column chromatography (SiO2, acetone:pentane 
1:9) to give the title compound  (±)-4C (134 mg, 35%) as a colourless oil. Anal. Calcd. for C16H20O6: C, 62.33; H, 6.54%. 
Found: C, 62.10; H, 6.43. 1Η NMR (300 MHz, CDCl3) 7.16-7.24 (m, 1 H), 6.79-6.85 (m, 3 H), 4.91 (s, 1 H), 4.69 (d, 1 H, 
J = 12.09 Hz), 4.50 (d, 1 H, J = 12.08 Hz), 4.41 (d, 1 H, J = 6.95 Hz), 4.37 (d, 1 H, J = 6.95 Hz), 4.17 (d, 1 H, J = 16.48 
Hz), 4.10 (d, 1 H, J = 16.48 Hz), 3.75 (s, 3 H), 1.44 (s, 3 H) and 1.31 (s, 3 H). 13C NMR (50.3 MHz, CDCl3) 203.1, 159.8, 
137.7, 129.6, 120.2, 113.6, 113.5, 111.9, 96.4, 77.7, 75.3, 69.8, 65.9, 55.2, 26.6 and 25.3. MS (EI): m/z 308 (M+, 10), and 




Prepared according to the procedure for (±)-4C from (-)-2C (234 mg, 1 mmol) to give (+)-4C (97% de, 130 mg, 42%). 




To a solution of (±)-4C (48 mg, 0.156 mmol) in THF (4 ml) at –20 oC under argon was added zinc borohydride (0.313 
ml, 0.156 mmol, 0.5 M in diethyl ether). The resulting mixture was stirred for 15 min and H2O (4 ml) was added. 
Following extraction with CH2Cl2 (3 x 5 ml), drying over Na2SO4 and concentration in vacuo, the residue was purified by 
chromatography (SiO2, acetone/pentane 1:4) to give the title compound (±)-5C  (40 mg, 83%) as a colourless waxy solid. 
1Η NMR (200 MHz, CDCl3) 7.29-7.22 (m, 1 H), 6.94-6.80 (m, 3 H), 4.77 (d, 1 H, J = 11.96 Hz), 4.77 (d, 1 H, J = 3.17 
Hz), 4.54 (d, 1 H, J = 11.96 Hz), 4.41 (dd, 1 H, J = 4.15 and 6.35 Hz), 4.14 (dd, 1 H, J = 3.41 and 6.34 Hz), 4.05 (m, 1 
H), 3.84 (dd, 1 H, J = 4.39 and 10.98 Hz), 3.80 (s, 3 H), 3.61 (dd, 1 H, J = 8.06 and 11.23 Hz), 2.26 (d, 1 H, J = 8.55 Hz), 
1.49 (s, 3 H) and 1.37 (s, 3 H). 13C NMR (75 MHz, CDCl3) 159.6, 138.7, 129.4, 120.2, 113.4, 113.3, 109.9, 97.7, 75.1, 
73.0, 69.5, 64.2, 62.4, 55.2, 27.5 and  25.3. MS (EI): m/z 310 (M+, 2%), 295 (MH-O, 9), 189 (M- CH3OC6H4CH2, 32) and 
121 (CH3OC6H4CH2, 100). HRMS calcd. for C16H22O6: 310.14161. Found: 310.14240. 
 
(+)-4-(3-Methoxy-benzyloxy)-2,2-dimethyl-dihydro-[1,3]dioxolo[4,5-c]pyran-7-ol, (+)-5C 
Spectra included: 1H and 13C NMR 
 
Prepared according to the procedure for (±)-5C from (+)-4C (100 mg, 0.32 mmol) to give (+)-5C (96% de, 88 mg, 88%). 




Prepared according to the procedure for (±)-2A from palladium (II) acetate (1.5 mg, 10 mol%, 0.0065 mmol), 
triphenylphosphite (4.4 mg, 22 mol%, 0.014 mmol), (±)-5C (20 mg, 0.0065 mmol) and (±)-benzoyloxypyranone (±)-3 
(21 mg, 0.097 mmol) in DCM (1 ml). Purification of the residue by column chromatography (SiO2, 25-30% 
EtOAc/pentane gradient elution) gave 2 diastereomers of product 6C (15 mg, 58%) as a colourless oil. 1Η NMR (300 
MHz, CDCl3) 7.23-7.29 (m, 1 H), 6.83-6.94 (m, 4 H), 6.15 (d, J = 10.62 Hz, 1 H), 5.40 (d, J = 3.30 Hz, 0.35 H, 
diastereomer 1), 5.34 (d, J = 2.93 Hz, 0.65 H, diastereomer 2), 4.81-4.07 (m, 8 H), 3.91-3.69 (m, 2 H), 3.81 (s, 3 H), 1.47 
(s, 1.05 H, diastereomer 1), 1.44 (s, 1.95 H, diastereomer 2) and 1.36 (s, 3 H, diastereomers 1 and 2). 13C NMR (75 
MHz, CDCl3) 194.3, 194.0, 159.7, 143.6, 143.3, 138.7, 129.4, 128.2, 120.23, 120.17, 113.5, 113.42, 113.36, 110.7, 110.5, 
98.8, 98.3, 93.6, 93.1, 75.9, 75.8, 73.7, 72.0, 71.7, 71.0, 69.9, 69.8, 66.4, 66.3, 61.2, 60.3, 55.2, 27.0, 26.8 and 25.5. MS 
(EI): m/z 406 (M+, 1%), 391 (M-CH3, 1), 285 (M-MeOBn, 3), 121 (Bn, 57) and 97 (C5H5O2, 100). HRMS calcd. for 









Spectra included: 1H and 13C NMR 
 
Prepared according to the procedure for 6(S)-(-)-2G from tris(dibenzylideneacetone)dipalladium (0)  (3.3 mg, 5 mol%, 
0.0035 mmol), triphenylphosphine (4.1 mg, 22 mol%, 0.016 mmol), (+)-5C (22 mg, 0.071 mmol) and (-)-6-acetoxy-2H-
pyran-3(6H)-one (-)-1 (17 mg, 0.11 mmol) in DCM (2.5 ml) under argon at –10 oC. Purification of the residue (96% de 
by 1H NMR) by column chromatography (SiO2, 5-10% acetone/pentane, gradient elution) gave product 6(R)-6C (16 mg, 
55 %) as a colourless oil. [α]D = +3.2o  (c 0.73, CH2Cl2). 1Η NMR (300 MHz, CDCl3) 7.23-7.29 (m, 1 H), 6.83-6.94 (m, 4 
H), 6.15 (d, J = 10.25 Hz, 1 H), 5.34 (d, J = 3.29 Hz, 1 H), 4.79 (d, J = 12.08 Hz, 1 H), 4.70-4.56 (m, 4 H), 4.34-4.27 (m, 
1 H), 4.13-4.07 (m, 2 H), 3.87-3.68 (m, 2 H), 3.81 (s, 3 H), 1.44 (s, 3 H) and 1.37 (s, 3 H). 13C NMR (75 MHz, CDCl3) 
194.3, 159.7, 143.3, 138.7, 129.5, 128.2, 120.2, 113.41, 113.36, 110.5, 98.8, 93.6, 75.9, 73.7, 71.7, 69.9, 66.4, 60.3, 55.2, 
27.0 and 25.5. MS (EI): m/z 406 (M+, 1%), 391 (M-CH3, 3), 285 (M-MeOBn, 3), 121 (Bn, 54) and 97 (C5H5O2, 100). 






To palladium (II) acetate (0.8 mg, 5 mol%, 3.5 µmol) in a flame-dryed Schlenck tube under argon was added a solution 
of triphenylphosphite (2.4 mg, 11 mol%, 7.6 µmol) in DCM (1.5 ml) via cannula. After stirring the yellow solution at 
ambient temperature for 10 min, 3-methoxybenzyl alcohol (14.3 mg, 13 µl, 0.104 mmol) was added via microsyringe. 
After further stirring for 10 min (±)-6-(tert-butyldimethylsilanyloxymethyl)-5-oxo-5,6-dihydro-2H-pyran-2-yl benzoate 
(±)-7 (25 mg, 0.069 mmol) was added as a solid and the mixture was stirred in the dark for 24 h. The homogeneous 
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give the title compound  (19 mg, 73%) as a colourless oil. 1Η NMR (300 MHz, CDCl3) 7.31-7.26 (m, 1 H), 6.97-6.85 (m, 
4 H), 6.12 (d, 1 H, J = 10.25 Hz), 5.40 (d, 1 H, J = 3.30 Hz), 4.85 (d, 1 H, J = 11.72 Hz), 4.75 (d, 1 H, J = 11.72 Hz), 4.50 
(dd, 1 H, J = 5.12 and 2.56 Hz), 4.10-4.00 (m, 2 H), 3.82 (s, 3 H) 0.89 (s, 9 H) and 0.09 (s, 6 H). 13C NMR (75 MHz, 
CDCl3)  194.6, 159.8, 143.7, 138.6, 129.6, 128.3, 120.4, 113.62, 113.57, 92.0, 76.2, 70.3, 62.5, 55.2, 25.8, 18.3, -5.3 and 
–5.4. MS (CI) for C20H30O5Si: m/z 396 (M + NH4)+, 100%) and 379 (MH, 50). HRMS (M-CH3) calcd. for C19H27O5Si: 
363.16276. Found: 363.16382. 
 
(-)-2(R)-(tert-Butyl-dimethyl-silanyloxymethyl)-6(S)-(3-methoxy-benzyloxy)-6H-pyran-3-one (2R,6S)-8 
Spectra included: 1H and 13C NMR 
 
To palladium (II) acetate (1.6 mg, 10 mol%, 6.9 µmol) in a flame-dryed Schlenk tube under argon was added a solution 
of triphenylphosphite (4.7 mg, 22 mol%, 15.2 µmol) in DCM (1.5 ml) via cannula. After stirring the yellow solution at 
ambient temperature for 10 min, 3-methoxybenzyl alcohol (14.3 mg, 13 µl, 0.104 mmol) was added via microsyringe. 
After further stirring for 10 min and cooling to –10 oC, (-)-6-(tert-butyldimethylsilanyloxymethyl)-5-oxo-5,6-dihydro-2H-
pyran-2-yl benzoate (2R,6R)-7 (25 mg, 0.069 mmol) was added as a solid and the mixture was stirred in the dark for 24 h. 
The homogeneous orange solution was preadsorbed on silica and purified by flash column chromatography (SiO2, 
acetone:pentane 4:96) to give the title compound  (23 mg, 88%) as a colourless oil. [α]D = -38.6o  (c 0.12, CH2Cl2) 
 
Benzoic acid 6,6-dimethyl-5-oxo-5,6-dihydro-2H-pyran-2-yl ester, (±)-9 
 
The racemate (±)-9 was prepared according to a literature procedure and was resolved by preparative HPLC on a 
Chiralcel OD column, iso-propanol:heptane 1:99 (RTs 10.1 and 11.5 min) 
 




Prepared according to the procedure for (±)-2A from palladium (II) acetate (6.8 mg, 5 mol%, 0.03 mmol), 
triphenylphosphite (20.5 mg, 11 mol%, 0.066 mmol), 3-methoxybenzyl alcohol (55 mg, 50 µl, 0.4 mmol) and (±)-6-
acetoxy-2,2-dimethyl-pyran-3(6H)-one (110 mg, 0.6 mmol) in DCM (3 ml). Purification of the residue by column 
chromatography (SiO2, acetone:pentane 1:19) gave product (±)-10 (83 mg, 79%) as a colourless oil. 1Η NMR (300 MHz, 
CDCl3) 7.29-7.23 (m, 1 H), 6.94-6.80 (m, 4 H), 6.05 (d, 1 H, J = 10.26 Hz), 5.34 (d, 1 H, J = 2.92 Hz), 4.88 (d, 1 H, J = 
11.72 Hz), 4.60 (d, 1 H, J = 11.72 Hz), 3.79 (s, 3 H), 1.54 (s, 3 H) and 1.39 (s, 3 H). 13C NMR (75 MHz, CDCl3) 199.3, 
159.8, 143.9, 138.7, 129.6, 126.3, 120.3, 113.5, 113.4, 92.1, 79.3, 69.7, 55.2, 27.0 and 24.9. MS (EI): m/z 262 (M+, 1%), 
204 (M-C3H6O, 3%). HRMS calcd. for C15H18O4: 262.12049. Found: 262.12134. 
 
(-)-6-(3-Methoxy-benzyloxy)-2,2-dimethyl-pyran-3(6H)-one, (-)-10 
Spectra included: 1H and 13C NMR 
 
Prepared according to the procedure for 6(S)-2G from tris(dibenzylideneacetone)dipalladium (0)  (2.5 mg, 5 mol%, 
0.0027 mmol), triphenylphosphine (3.1 mg, 22 mol%, 0.0119 mmol), 3-methoxybenzyl alcohol (7.5 mg, 6.7 µl, 0.054 
mmol) and (-)-6-benzoyloxy-2,2-dimethyl-pyran-3(6H)-one (-)-9 (20 mg, 0.08 mmol) in DCM (1.5 ml) under argon at –
10 oC. Purification of the residue by flash column chromatography (SiO2, 5% EtOAc/pentane) gave product (-)-10 (11 




Spectra included: 1H and 13C NMR 
 
To a solution of (-)-6-[5-(2,2-dimethyl-[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yloxy]-6H 
-pyran-3-one 6-(S)-(-)-2I (16 mg, 0.045 mmol) in acetone (0.4 ml) and tert-butanol (0.4 ml) was added a molar excess of 
a 1:1 (w/w) solution of 4-methylmorpholine-N-oxide (12 mg, 0.09 mmol) in water. The solution was cooled to 0 oC and a 
catalytic amount (2 mol%) of OsO4 was added. After stirring for 6 h the mixture was quenched with Na2SO3 sat. aq., 
extracted with EtOAc (4 x 5 ml) dried over Na2SO4 and concentrated. The crude mixture containing the dihydroxylated 
product was submitted to th efollowing conditions without further purification. 
To a solution of the residue obtained from dihydroxylation in acetone (1 ml) was added 2,2-dimethoxypropane (0.1 ml) 
and a catalytic amount of PTSA (5 mol%). The mixture was stirred at ambient temperature for 16 h. Quenching of the 

















i. OsO4, NMO, tBuOH, Acetone, H2O; ii. 2,2-DMP, Acetone, PTSA
2I 4I
flash column chromatography (SiO2, 5% acetone/pentane) gave the title compound 4I (0.8 mg, 4%) as a colourless oil. 1H 
NMR (CDCl3, 300 MHz) 5.88 (d, J = 3.66 Hz, 1 H), 5.12 (s, 1 H), 4.61-4.55 (m, 2 H), 4.40-4.36 (m, 3 H), 4.23-4.07 (m, 
4H), 3.95 (dd, J = 8.43 and 4.76 Hz, 1 H), 1.52 (s, 3 H), 1.51 (s, 3 H), 1.41 (s, 3 H), 1.38 (s, 3 H) and 1.32 (s, 6 H). 13C 
NMR (75 MHz, CDCl3) 203.0, 118.5, 112.2, 109.5, 105.1, 94.9, 81.8, 80.7, 77.6, 77.5, 75.1, 71.5, 67.7, 65.8, 26.8, 26.7, 
26.7, 26.1, 25.4 and 25.1. MS (CI) for C20H30O10: m/z 448 (M + NH4)+, 81%) and 431 (MH+, 100). 
 
 




Column Eluent Retention times  
min-1 
de/ee % 
(±)-1 GC Lipodex C, 50 
m x 0.25mm ID 
95 oC oven, Flow Rate 
1.3 mlmin-1 
26.1 and 27.4 rac 
(-)-1 GC Lipodex C, 50 
m x 0.25mm ID 
95 oC oven, Flow Rate 
1.3 mlmin-1 
27.4 >99 
(±)-2A HPLC Chiralpak AD 95/5 heptane/IPA 6.9 and 7.9 rac 
2A HPLC Chiralpak AD 95/5 heptane/IPA 7.9 94 
(±)-2B HPLC  Chiralpak AD 99/1 heptane/IPA 26.6 and 31.6 rac 
(-)-2B
 
HPLC  Chiralpak AD 99/1 heptane/IPA 31.6 98* 
(±)-2C HPLC  Chiralpak AD 99/1 heptane/IPA 23.0 and 28.3 rac 
(-)-2C
 
HPLC  Chiralpak AD 99/1 heptane/IPA 28.3 99 
(±)-2D HPLC Chiralcel OD 90/10 heptane/IPA 10.7 and 11.7 rac 
(-)-2D
 
HPLC Chiralcel OD 90/10 heptane/IPA 11.7 98 
2F
 
HPLC Chiralpak AS 90/10-60/40 hep/IPA 23.2 and 26.1 2 x diast. 
(-)-2F
 
HPLC Chiralpak AS 90/10-60/40 hep/IPA 26.1 97 
(±)-3 HPLC Chiralpak AS 90/10 heptane/IPA 8.3 and 10.7 rac 
(+)-3
 
HPLC Chiralpak AS 90/10 heptane/IPA 8.3 99 
(-)-3
 
HPLC Chiralpak AS 90/10 heptane/IPA 10.7 99 
(±)-4C HPLC Chiralcel OD 95/5 heptane/IPA 16.1 and 19.1 98 de 
(+)-4C
 
HPLC Chiralcel OD 95/5 heptane/IPA 19.1 97 de 
(±)-5C HPLC Chiralcel OD 90/10 heptane/IPA 10.9 and 14.8 98 de 
(+)-5C
 
HPLC Chiralcel OD 90/10 heptane/IPA 14.8 96 de 
(±)-7 HPLC Chiralcel OD 99/1 heptane/IPA 10.6 and 11.9 rac 
7 HPLC Chiralcel OD 99/1 heptane/IPA 10.6 99 
(±)-9 HPLC Chiralcel OD 99/1 heptane/IPA 10.1 and 11.5 rac 
(-)-9 HPLC Chiralcel OD 99/1 heptane/IPA 10.1  99 
(±)-10 HPLC Chiralpak AD 99/1 heptane/IPA 10.1 and 11.2 rac 
(±)-10 HPLC Chiralpak AD 99/1 heptane/IPA 11.2 95 
*before flash column chromatography (SiO2) 

























 
